Search Within

James Joseph Harding

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (48)
  2. Journal Article (41)
Groups
  1. Department of Medicine (89)
  2. Epidemiology and Biostatistics (89)
  3. Gastrointestinal Oncology Service (89)
  4. Solid Tumor Oncology Division (89)
  5. Center for Pancreatic Cancer Research (75)
  6. Biostatistics Service (63)

More Groups

People
  1. Ghassan Abou-Alfa (69)
  2. Eileen O'Reilly (46)
  3. William Jarnagin (43)
  4. Marinela Capanu (36)
  5. Joanne Chou (29)
  6. Michael Berger (29)

More People

Years
  1. 2025 (4)
  2. 2024 (16)
  3. 2023 (9)
  4. 2022 (7)
  5. 2021 (5)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (38)
  2. Clinical Cancer Research (8)
  3. Annals of Surgical Oncology (7)
  4. JCO Precision Oncology (6)
  5. Cancer (5)
  6. The Oncologist (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (46)
  2. American Association for Cancer Research (10)
  3. Springer (8)
  4. Wiley Blackwell (7)
  5. Oxford University Press (6)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (89)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel
    Journal Article

    Smyth, L. M.; Monson, K. R.; Jhaveri, K.; Drilon, A.; Li, B. T.; Abida, W.; Iyer, G.; Gerecitano, J. F.; Gounder, M.; Harding, J. J.; more...
    Investigational New Drugs (2017)

    Fulltext@MSK | Save
  • A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma
    Journal Article

    Lowery, M. A.; Yu, K. H.; Kelsen, D. P.; Harding, J. J.; Bomalaski, J. S.; Glassman, D. C.; Covington, C. M.; Brenner, R.; Hollywood, E.; Barba, A.; more...
    Cancer (2017)

    Fulltext@MSK | Save
  • Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
    Journal Article

    Momtaz, P.; Harding, J. J.; Ariyan, C.; Coit, D. G.; Merghoub, T.; Gasmi, B.; You, D.; Viale, A.; Panageas, K. S.; Samoila, A.; more...
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Real-time genomic profiling of pancreatic ductal adenocarcinoma: Potential actionability and correlation with clinical phenotype
    Journal Article

    Lowery, M. A.; Jordan, E. J.; Basturk, O.; Ptashkin, R. N.; Zehir, A.; Berger, M. F.; Leach, T.; Herbst, B.; Askan, G.; Maynard, H.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
    Journal Article

    Zehir, A.; Benayed, R.; Shah, R. H.; Syed, A.; Middha, S.; Kim, H. R.; Srinivasan, P.; Gao, J.; Chakravarty, D.; Devlin, S. M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention
    Meeting Abstract

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Kemeny, N. E.; O'Reilly, E. M.; Jarnagin, W. R.; Harding, J. J.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic profiling of pancreas ductal adenocarcinoma (PDA), actionability, and correlation with clinical phenotype
    Meeting Abstract

    Jordan, E.; Lowery, M. A.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Maynard, H.; Glassman, D. C.; Covington, C. M.; Schultz, N.; Abou-Alfa, G. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Identification of potentially actionable molecular alterations in advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Heins, Z. J.; Connell, L. C.; Soumerai, T.; Kemeny, N. E.; Jarnagin, W. R.; O'Reilly, E. M.; DeMatteo, R. P.; D'Angelica, M. I.; Lowery, M. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Second-line chemotherapy (CTx) outcomes in advanced biliary cancers (ABC): A retrospective multicenter analysis
    Meeting Abstract

    Goff, L. W.; Lowery, M. A.; Jordan, E.; Wang, R.; Bocobo, A. G.; Chou, J. F.; O'Reilly, E. M.; Harding, J. J.; Kemeny, N. E.; Capanu, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Second-line chemotherapy (CTx) outcomes in advanced biliary cancers (ABC): A retrospective multicenter analysis
    Meeting Abstract

    Lowery, M. A.; Goff, L. W.; Jordan, E.; Wang, R.; Bocobo, A. G.; Chou, J. F.; O'Reilly, E. M.; Harding, J. J.; Kemeny, N. E.; Capanu, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save